Relay Therapeutics Inc (RLAY)

Relay Therapeutics Inc (RLAY) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $4B; returns 1 day -0.9%, 1 week +11.7%, 1 year +168.9%.

Relay Therapeutics Inc. (RLAY) is a clinical-stage precision medicine company focused on transforming the drug discovery process by integrating cutting-edge computational and experimental technologies.

Groups RLAY belongs to

• Precision Medicine
• Biotechnology
• Clinical Stage Biotech
• Clinical Stage
• Oncology
• Drug Discovery
• Artificial Intelligence
• Machine Learning
• Cancer Therapeutics
• Breast Cancer Treatment
• Life Sciences

RLAY financial model: income statement, cash flow and balance sheet